Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders (Q29618853)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

myeloproliferative disorders

30 April 2017

main subject

1 reference

Baxter EJ

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

Scott LM

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

Campbell PJ

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

East C

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

Fourouclas N

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

Swanton S

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

Vassiliou GS

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

Bench AJ

8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

Boyd EM

9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

Curtin N

10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

Scott MA

11

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

Erber WN

12

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

Green AR

13

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

March 2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

volume

365

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

issue

9464

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

page(s)

1054-61

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

Chronic myeloproliferative disorders

30 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Polycythemia vera: stem-cell and probable clonal origin of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Management of the myeloproliferative disorders : distinguishing data from dogma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Chronic myeloproliferative disorders: molecular markers and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Letter: Tinel sign in carpal-tunnel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin‐3

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Pathogenesis of polycythaemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Receptor tyrosine kinases in normal and malignant haematopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Efficacy and safety of low-dose aspirin in polycythemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Evaluation of diagnostic criteria in polycythemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

PRV-1 mRNA expression discriminates two types of essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Regulation of the Jak2 tyrosine kinase by its pseudokinase domain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Expression of Bcl-x in erythroid precursors from patients with polycythemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971142-9

7 January 2021

10.1016/S0140-6736(05)71142-9

Identifiers

DOI

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15781101

30 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1269783

OpenCitations bibliographic resource ID

1269783

1 reference